홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GALT
#3043
Galectin Therapeutics Inc.
2.9
8
-1.32%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.32%
월간 변동
-5.40%
6달 변화
-25.87%
년간 변동율
+104.11%
이전 종가
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
양
21
마켓
주식
헬스케어
GALT
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
57.16 M
59.36 M
59.44 M
61.9 M
63.18 M
—
Valuation ratios
Enterprise value
101.41 M
83.75 M
52.06 M
82.55 M
66.88 M
521.06 M
Price to earnings ratio
—
-3.98
-1.82
-2.35
-1.7
-13.87
Price to sales ratio
—
877.9
125.82
242.31
136.7
146.11
Price to cash flow ratio
—
-4.98
-2.26
-3.18
-1.92
-16.37
Price to book ratio
—
331.01
-2.04
-1.68
-0.76
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.79
0.73
1.82
1.46
2.69
2.81
Return on equity %
1.04
34.18
1.14
0.66
0.45
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
21.87 K
6 885.46
8 812.96
7 216.5
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
22.12 K
6 961.58
9 506.02
8 001.19
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.46
4.63
1.58
1.77
0.49
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0.02
0.02
0.03
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.42
0.52
0.55
0.67
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.68
0.31
0.43
0.24
0.76
Net current asset value per share
—
0.71
0.35
0.46
0.28
0.87
Tangible book value per share
—
0.01
0.56
1.02
1.67
7.28
Working capital per share
—
0.56
0.13
0.2
-0.29
-3.75
Book value per share
—
0.01
0.56
1.02
1.67
7.28
뉴스
갈락틴 테라퓨틱스 이사, 마크 루빈 사임
Galectin Therapeutics director Marc Rubin resigns from board
Galectin Therapeutics CFO, 23.3만 달러 상당 주식 매도
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics, FDA 피드백 후 주가 폭락
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA provides feedback on Galectin’s belapectin development program
갈렉틴 테라퓨틱스 이사, 105만 달러 상당 주식 매도
갈렉틴 테라퓨틱스, 이사진 선임 및 주요 제안 승인
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)